Agenda

8:40

Dr Christelle Kerouedan, Instinctif Partners

Introduction of Instinctif Partners Communication Clinic

8:50

Nasdaq opening ceremony

Carsten Borring, AVP and Head of Listings & Capital Markets, Nasdaq Copenhagen

9.10

Anette Orheim – Medicon Village

Welcome and introduction

9.20

Petter Hartman – Medicon Valley Alliance

Creating opportunities by working together

9.30

Key Note speaker: Sarah Haywood – MedCity

The Genomics Revolution – why 2018 is the year of genomics driven precision medicine in the UK’s Golden Triangle

9.45

Kerstin Jakobsson, Medicon Village – CAMP project

A new era for individualized treatments with Centre for Advanced Medical Products (CAMP) – Southern Sweden´s contribution to the National initiative

10.00

Johan Inboor – Peptonic Medical

Turning failure to success and leading the way in genderalised medicine

10.15

Tony Jones – One Nucleus

Energising SME Engagement in Policy-Driven Opportunities

10.30

Coffee Break

11.00

Lasse Boding – The Danish National Biobank

Research infrastructure that paves the way for personalised medicine

11.15

Allan Flyvbjerg – Steno Diabetes Center Copenhagen (SDCC), Region Hovedstaden and Copenhagen University

The unique opportunities in Denmark within ‘Precision medicine’

11.30

Lars Lindsköld – Swelife SWEPER

Using the force in data for Personalised Medicine in Sweden

11.45

Nick Lench – Congenica

Integrating genomics in mainstream healthcare

12.00

Lunch break

13.00

Dragons Den

13.45

Steve Smith – Potter Clarkson

Protecting your precision medicine innovations; the importance of patents in getting your ideas into the clinic

14.00

Jonathan Robinson – Abzena

Enabling next generation biopharmaceuticals

14.15

Dorte X. Gram – Pila Pharma

How Pila Pharma was created and how did we get our target patient profile?

14.30

Lars Hedbys, Idogen & Evy Lundgren-Åkerlund, Xintela

At the forefront of cell therapy at Medicon Village

14.45

Abel Ureta-Vidal – Eagle Genomics

About measuring the value of information, its importance to support data governance and drive innovation in Life Sciences R&D

15.00 – 15.30

Coffee break

15.30

AstraZeneca – Susanna Myhre

Partnering for scientific leadership

15.45

Johan Liwing –  Johnson & Johnson

Swedish Collaborative Real World Big Data Analytics through OHDSI

16.00

Panel debate

How can we ensure the patient is getting the best treatment on the market?

  • Helen Frost – Leo Pharma Open Innovation
  • Lars Lindsköld – Project Leader at Swelife
  • Dr. med. Karen Czeloth – EAU/ReproUnion scholarship Postdoc at the Department of Growth and Reproduction
    Copenhagen University Hospital

16.30

Conclusion

17.00

Nasdaq closing ceremony, networking and drinks reception